ANVS | Annovis Bio, Inc. Annual & Quarterly Income

Annual Income Statements

(In USD)

Breakdown	2023	2022	2021	2020	2019	2018
Revenue	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expenses	45.03 Million	25.51 Million	14.5 Million	5.48 Million	870.54 Thousand	713.93 Thousand
Selling, General and Administrative Expenses	6.24 Million	8.99 Million	6.05 Million	3.58 Million	829.36 Thousand	602.32 Thousand
Research and Development Expenses	38.79 Million	16.51 Million	8.47 Million	3.05 Million	776.25 Thousand	111.6 Thousand
Other Expenses	-	-	-36.75 Thousand	-1.15 Million	-735.07 Thousand	-
Cost and Expenses	45.03 Million	25.51 Million	14.5 Million	5.48 Million	870.54 Thousand	713.93 Thousand
Operating Income	-45.03 Million	-25.51 Million	-14.53 Million	-6.64 Million	-1.6 Million	-713.93 Thousand
Interest Expense	-	-	-	47.22 Million	-	66.00
Income Tax Expense	-	-182.71 Thousand	-50.08 Thousand	-1.2 Million	-694.14 Thousand	-132.00
Earnings before Tax	-56.2 Million	-25.32 Million	-14.48 Million	-5.46 Million	-990.98 Thousand	-713.87 Thousand
Net Income	-56.2 Million	-25.14 Million	-14.43 Million	-4.25 Million	-296.83 Thousand	-713.87 Thousand
Earnings Per Share Basic	-6.23	-3.08	-1.89	-0.67	-0.07	-0.16
Earnings Per Share Diluted	-6.23	-3.08	-1.89	-0.67	-0.07	-0.16
Weighted Average Shares Outstanding	9.02 Million	8.16 Million	7.62 Million	6.3 Million	4.49 Million	4.39 Million
Weighted Average Shares Outstanding (Diluted)	9.02 Million	8.16 Million	7.62 Million	6.3 Million	4.49 Million	4.39 Million
Gross Margin	-	-	-	-	-	-
EBIT Margin	-	-	-	-	-	-
Profit Margin	-	-	-	-	-	-
EBITDA	-45.03 Million	-	-	-	-	66.00
Earnings Before Tax Margin	-	-	-	-	-	-

Breakdown	2024 Q2	2024 Q1	2023 Q4	2023 FY	2023 Q3	2023 Q2
Revenue	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expenses	7.76 Million	7.8 Million	10.44 Million	45.03 Million	14.86 Million	9.75 Million
Selling, General and Administrative Expenses	1.97 Million	1.29 Million	1.53 Million	-	1.02 Million	1.49 Million
Research and Development Expenses	5.78 Million	6.51 Million	8.9 Million	-	13.83 Million	8.26 Million
Other Expenses	-	-	-	-	-	-
Cost and Expenses	7.76 Million	7.8 Million	10.44 Million	45.03 Million	14.86 Million	9.75 Million
Operating Income	-7.76 Million	-7.8 Million	-10.44 Million	-45.03 Million	-14.71 Million	-9.75 Million
Interest Expense	-	-	-19.7 Million	-	-	-
Income Tax Expense	2.00	3.00	-10.44 Thousand	-45.03 Thousand	131.79 Thousand	-9759.70
Earnings before Tax	-5.02 Million	-1.06 Million	-22.21 Million	-56.2 Million	-14.71 Million	-9.53 Million
Net Income	-5.02 Million	-1.06 Million	-22.21 Million	-56.2 Million	-14.71 Million	-9.53 Million
Earnings Per Share Basic	-0.44	-0.10	-2.33	-	-1.63	-1.07
Earnings Per Share Diluted	-0.44	-0.10	-2.33	-	-1.63	-1.07
Weighted Average Shares Outstanding	11.3 Million	10.62 Million	9.52 Million	9.02 Million	9.01 Million	8.95 Million
Weighted Average Shares Outstanding (Diluted)	11.3 Million	10.62 Million	9.52 Million	9.02 Million	9.01 Million	8.95 Million
Gross Margin	-	-	-	-	-	-
EBIT Margin	-	-	-	-	-	-
Profit Margin	-	-	-	-	-	-
EBITDA	-7.76 Million	-7.8 Million	-10.44 Million	-	-14.71 Million	-9.75 Million
Earnings Before Tax Margin	-	-	-	-	-	-